These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 3045234)

  • 1. Inhibition of the activation of Hageman factor (factor XII) by platelet factor 4.
    Dumenco LL; Everson B; Culp LA; Ratnoff OD
    J Lab Clin Med; 1988 Sep; 112(3):394-400. PubMed ID: 3045234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory action of amyloid precursor protein against human Hageman factor (factor XII).
    Niwano H; Embury PB; Greenberg BD; Ratnoff OD
    J Lab Clin Med; 1995 Feb; 125(2):251-6. PubMed ID: 7844473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Hageman factor (factor XII) by sulfatides and other agents in the absence of plasma proteases.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Jul; 102(1):31-45. PubMed ID: 6343536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of the activation of Hageman factor (factor XII) by soluble human placental collagens types III, IV, and V.
    Koenig JM; Chahine A; Ratnoff OD
    J Lab Clin Med; 1991 Jun; 117(6):523-7. PubMed ID: 1646270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Hageman factor by collagen.
    Wilner GD; Nossel HL; LeRoy EC
    J Clin Invest; 1968 Dec; 47(12):2608-15. PubMed ID: 4302176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the activation of Hageman factor (factor XII) by aprotinin (Trasylol).
    Laurel MT; Ratnoff OD; Everson B
    J Lab Clin Med; 1992 May; 119(5):580-5. PubMed ID: 1374787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoni.
    Foster CB; Flanigan TP; DeStigter KK; Blanton R; Dumenco LL; Gallagher C; Ratnoff OD
    J Lab Clin Med; 1992 Nov; 120(5):735-9. PubMed ID: 1431502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of Hageman factor (factor XII) by bismuth subgallate, a hemostatic agent.
    Thorisdottir H; Ratnoff OD; Maniglia AJ
    J Lab Clin Med; 1988 Oct; 112(4):481-6. PubMed ID: 3171356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of the activation of Hageman factor (factor XII) by beta 2-glycoprotein I.
    Henry ML; Everson B; Ratnoff OD
    J Lab Clin Med; 1988 May; 111(5):519-23. PubMed ID: 3361230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relative amidolytic activity of Hageman factor (factor XII) and its fragments. The effect of high-molecular-weight kininogen and kaolin.
    Ratnoff OD
    J Lab Clin Med; 1980 Aug; 96(2):267-77. PubMed ID: 7400662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of clot-promoting and amidolytic activities in mixtures of Hageman factor (factor XII) and ellagic acid.
    Ratnoff OD; Saito H
    J Lab Clin Med; 1982 Aug; 100(2):248-60. PubMed ID: 7097109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the activation of Hageman factor (factor XII) by complement subcomponent C1q.
    Rehmus EH; Greene BM; Everson BA; Ratnoff OD
    J Clin Invest; 1987 Aug; 80(2):516-21. PubMed ID: 3038961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid loss of factor XII and XI activity in ellagic acid-activated normal plasma: role of plasma inhibitors and implications for automated activated partial thromboplastin time recording.
    Joist JH; Cowan JF; Khan M
    J Lab Clin Med; 1977 Dec; 90(6):1054-65. PubMed ID: 303667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).
    Cochrane CG; Wuepper KD
    J Exp Med; 1971 Oct; 134(4):986-1004. PubMed ID: 4106492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fletcher factor deficiency. A diminished rate of Hageman factor activation caused by absence of prekallikrein with abnormalities of coagulation, fibrinolysis, chemotactic activity, and kinin generation.
    Weiss AS; Gallin JI; Kaplan AP
    J Clin Invest; 1974 Feb; 53(2):622-33. PubMed ID: 11344577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.
    Wiggins RC; Loskutoff DJ; Cochrane CG; Griffin JH; Edgington TS
    J Clin Invest; 1980 Jan; 65(1):197-206. PubMed ID: 6444222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Activation mechanism of bovine factor XII on foreign surfaces--activation by polysaccharide sulfate and sulfatide and inhibition by platelet components].
    Kato H; Shimada T; Ohno Y; Sugo T; Kodama K
    Rinsho Byori; 1982 Jun; Suppl 50():102-13. PubMed ID: 6215509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.